Hybrid inhibitors of phosphatidylinositol 3-kinase (PI3K) and the mammalian target of rapamycin (mTOR): design, synthesis, and superior antitumor activity of novel wortmannin-rapamycin conjugates

Journal of Medicinal Chemistry
Semiramis Ayral-KaloustianKer Yu

Abstract

Hyperactivation of the PI3K/AKT/mTOR signaling pathway is common in cancer, and PI3K and mTOR act synergistically in promoting tumor growth, survival, and resistance to chemotherapy. Thus, combined targeting of PI3K and mTOR presents an opportunity for robust and synergistic anticancer efficacy. 17-Hydroxywortmannin (2a) analogues conjugated to rapamycin (3a) analogues via a prodrug linker are uniquely positioned for this approach. Our efforts led to the discovery of diester-linked conjugates that, upon in vivo hydrolysis, released two highly potent inhibitors. Conjugate 7c provided enhanced solubility relative to 3a and to an equivalent mixture of 3a and 9a and demonstrated profound activity in U87MG mouse xenografts, achieving an MED of 1.5 mg/kg, following weekly intravenous dosing. At 15 mg/kg, 7c completely inhibited the growth of HT29 tumors, whereas an equivalent mixture of the inhibitors was poorly tolerated. In the A498 renal tumor model, 7c exhibited superior efficacy over 3a or 9a when administered as a single agent or in combination with bevacizumab. Thus, we have uncovered a novel approach to target both PI3K and mTOR via hybrid inhibitors, leading to a broader and more robust anticancer efficacy.

References

Oct 1, 1984·The Journal of Antibiotics·C P EngC Vézina
Feb 13, 2001·International Journal of Pharmaceutics·P SimamoraS H Yalkowsky
Sep 25, 2002·Chemistry and Physics of Lipids·Yoshikatsu OgawaHiroaki Okuno
Oct 14, 2005·Journal of Medicinal Chemistry·Richard Morphy, Zoran Rankovic
Feb 3, 2006·Cancer Research·Kathryn E O'ReillyNeal Rosen
Jun 1, 2007·The New England Journal of Medicine·Gary HudesUNKNOWN Global ARCC Trial
Aug 2, 2007·Accounts of Chemical Research·Bernard Meunier
Sep 17, 2008·Oncogene·A Carracedo, P P Pandolfi
Apr 1, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Funda Meric-Bernstam, Ana Maria Gonzalez-Angulo
Apr 23, 2009·Science Signaling·David A Guertin, David M Sabatini
Apr 24, 2009·Natural Product Reports·Edmund I Graziani

❮ Previous
Next ❯

Citations

Dec 18, 2010·Journal of the American Chemical Society·Andrei V KarginovAlexander Deiters
Apr 23, 2011·Molecular Pharmaceutics·Wanyi TaiKun Cheng
Nov 1, 2011·Nature Reviews. Drug Discovery·Don BenjaminMichael N Hall
May 25, 2011·European Surgical Research. Europäische Chirurgische Forschung. Recherches Chirurgicales Européennes·E T PavlidisA K Sakantamis
Jan 14, 2012·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Andreas Müller-SchiffmannCarsten Korth
Aug 22, 2013·World Journal of Gastroenterology : WJG·Efstathios T Pavlidis, Theodoros E Pavlidis
Oct 21, 2011·Expert Opinion on Investigational Drugs·Bruno VincenziGiuseppe Tonini
Jun 16, 2015·Biochemical Pharmacology·Loana MussoFranco Zunino
May 30, 2019·Organic & Biomolecular Chemistry·Ping-Gui LiLiang-Hua Zou
Dec 15, 2015·Beilstein Journal of Organic Chemistry·Ivan BassaniniSergio Riva
Aug 21, 2012·Acta Crystallographica. Section E, Structure Reports Online·Lijun XieYuanrong Cheng
Jul 6, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Ronald A NelsonMark E Welker
May 19, 2012·Acta Crystallographica. Section E, Structure Reports Online·Lijun XieYuanrong Cheng
Mar 15, 2021·Pharmacology Research & Perspectives·Geng-Ruei ChangTo-Pang Chen
Apr 29, 2021·Organic & Biomolecular Chemistry·Shalini SinghWahajul Haq
May 6, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Marta SzumilakAndrzej Stanczak
May 21, 2010·Journal of Medicinal Chemistry·Kevin D Freeman-CookJoel Morris

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.